Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Suppression of hepatitis B virus with antiviral treatment lowered the risk of hepatocellular carcinoma by 58%.
People living with both viruses remain at risk for hepatocellular carcinoma despite antiviral therapy.
Many people with fatty liver disease have obesity, diabetes and other metabolic conditions.
Rates of liver complications were similar, but HIV-positive people had more non-liver cancers and non-liver-related deaths.
There is not a significant difference in three-year liver cancer survival rates between people living with HIV and people who are not.
Study in China sees an association with several cancer types, especially gastrointestinal malignancies.
HIV-positive people with a higher viral load over a longer period appear more likely to develop hepatocellular carcinoma.
HIV specialists may be much less likely than hepatologists to screen for hepatocellular carcinoma (HCC, the most common form of liver cancer)...
HIV-positive people who have liver transplants because of liver cancer have high survival rates.
People with HIV who undergo liver transplants for the most common form of liver cancer, appear to fare as well as those without the virus.
Three-year survival rates after a diagnosis of hepatocellular carcinoma (liver cancer) are similar between people living with HIV and HIV-nega...
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.